INTERVIEW Thibaut Hyvernat, CEO of Sterimed Infection Control “ Sterimed keeps production level despite Covid-19.” How would you describe your challenge was to not stop working and experience with the current crisis? get our employees on board in the new dynamic to respondto market needs . Sterimed Infection Control is one of theWe have thus placed great emphasis on leading suppliers of sterile medical de-protecting our employees and ensured vice packaging for plastic gloves, gauze,transparency and open communication syringes, or catheters for instance, usedin order to reassure them. both by hospitals and medical device manufacturers.We have 8 production What has changed in your way sites in the world, 2 of which are in Franceof working? in Amélie-les-Bains-Palalda (Pyrénées- Orientales) and Valenciennes (Nord). For a long time, Sterimed has been Unlike other companies, the crisis has carrying out its activity in equal parts in had a positive effect resulting in an ac-Asia (with two factories in China), Europe tivity peak. Order books have reached anand America (3 factories in the USA and increase of almost 100% for a few weeks.in Mexico).Given the high demand for We operate at our maximum capacity 24 surgical masks, our technical and com- hours a day, 7 days a week. The first pliance expertise, and our strong global